• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险信息披露对女性关于直接面向消费者的 BRCA 基因突变基因检测的信念的影响。

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

机构信息

Population Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

出版信息

Clin Genet. 2012 Jan;81(1):29-37. doi: 10.1111/j.1399-0004.2011.01797.x. Epub 2011 Nov 2.

DOI:10.1111/j.1399-0004.2011.01797.x
PMID:21992449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3846286/
Abstract

Despite an increase in direct-to-consumer (DTC) genetic testing, little is known about how variations in website content might alter consumer behavior. We evaluated the impact of risk information provision on women's attitudes about DTC BRCA testing. We conducted a randomized experiment; women viewed a 'mock' BRCA testing website without [control group (CG)] or with information on the potential risks of DTC testing [RG; framed two ways: unattributed risk (UR) information and risk information presented by experts (ER)]. Seven hundred and sixty-seven women participated; mean age was 37 years, mean education was 15 years, and 79% of subjects were white. Women in the RG had less positive beliefs about DTC testing (mean RG = 23.8, CG = 25.2; p = 0.001), lower intentions to get tested (RG = 2.8, CG = 3.1; p = 0.03), were more likely to prefer clinic-based testing (RG = 5.1, CG = 4.8; p = 0.03) and to report that they had seen enough risk information (RG = 5.3, CG = 4.7; p < 0.001). UR and ER exposure produced similar effects. Effects did not differ for women with or without a personal/family history of breast/ovarian cancer. Exposing women to the potential risks of DTC BRCA testing altered their beliefs, preferences, and intentions. Risk messages appear to be salient to women irrespective of their chance of having a BRCA mutation.

摘要

尽管直接面向消费者(DTC)的基因检测有所增加,但对于网站内容的差异如何改变消费者行为,人们知之甚少。我们评估了风险信息提供对女性对 DTC BRCA 检测的态度的影响。我们进行了一项随机实验;女性浏览了一个“模拟”BRCA 检测网站,没有[对照组(CG)]或有关于 DTC 检测的潜在风险信息[RG;以两种方式呈现:归因风险(UR)信息和专家呈现的风险信息(ER)]。767 名女性参与了研究;平均年龄为 37 岁,平均受教育年限为 15 年,79%的受试者为白人。RG 组的女性对 DTC 检测的看法不太积极(平均 RG=23.8,CG=25.2;p=0.001),检测意愿较低(RG=2.8,CG=3.1;p=0.03),更倾向于选择诊所检测(RG=5.1,CG=4.8;p=0.03),并表示已经看到足够的风险信息(RG=5.3,CG=4.7;p<0.001)。UR 和 ER 暴露产生了类似的效果。对于有或没有乳腺癌/卵巢癌个人/家族病史的女性,效果没有差异。向女性暴露于 DTC BRCA 检测的潜在风险改变了她们的信念、偏好和意图。风险信息似乎对女性很重要,而与她们是否有 BRCA 突变的机会无关。

相似文献

1
The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.风险信息披露对女性关于直接面向消费者的 BRCA 基因突变基因检测的信念的影响。
Clin Genet. 2012 Jan;81(1):29-37. doi: 10.1111/j.1399-0004.2011.01797.x. Epub 2011 Nov 2.
2
Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.有个人或家族乳腺癌或卵巢癌病史的女性中BRCA突变的风险信息暴露与直接面向消费者的基因检测
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1303-11. doi: 10.1158/1055-9965.EPI-08-0825. Epub 2009 Mar 24.
3
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.前瞻性三阴性乳腺癌登记处的种系BRCA突变评估:对遗传性乳腺癌和/或卵巢癌综合征检测的意义。
Breast Cancer Res Treat. 2014 Jun;145(3):707-14. doi: 10.1007/s10549-014-2980-0. Epub 2014 May 7.
4
Beyond BRCA: A Case Series Examining the Advent of Multigene Panel Testing.超越BRCA:一个多基因检测出现的病例系列研究
Clin Breast Cancer. 2018 Aug;18(4):e431-e439. doi: 10.1016/j.clbc.2018.03.015. Epub 2018 Apr 6.
5
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.来自遗传性乳腺癌和卵巢癌家族的BRCA突变阴性女性:对BRCA阴性经历的定性研究
Health Expect. 2008 Sep;11(3):220-31. doi: 10.1111/j.1369-7625.2008.00494.x.
6
Reproductive decision-making in young female carriers of a BRCA mutation.年轻女性 BRCA 基因突变携带者的生殖决策。
Hum Reprod. 2013 Apr;28(4):1006-12. doi: 10.1093/humrep/des441. Epub 2013 Jan 4.
7
Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population.印度人群遗传性乳腺癌和卵巢癌BRCA1/2基因的突变谱分析
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4145-4151. doi: 10.31557/APJCP.2024.25.12.4145.
8
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.BRCA1 和 BRCA2 基因突变检测在年轻乳腺癌女性中的应用。
JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.
9
Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.医疗机构与美国 BRCA 基因突变风险女性讨论基因检测。
Am J Prev Med. 2018 Feb;54(2):221-228. doi: 10.1016/j.amepre.2017.10.015. Epub 2017 Dec 11.
10
Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.在安大略省西南部诊断出乳腺癌后识别 BRCA 基因突变风险。
Can Fam Physician. 2012 May;58(5):e258-66.

引用本文的文献

1
Considerations for developing regulations for direct-to-consumer genetic testing: a scoping review using the 3-I framework.制定直接面向消费者的基因检测法规的考量:使用3-I框架的范围综述
J Community Genet. 2022 Apr;13(2):155-170. doi: 10.1007/s12687-022-00582-3. Epub 2022 Feb 16.
2
Secondary Data Usage in Direct-to-Consumer Genetic Testing: To What Extent Are Customers Aware and Concerned?直接面向消费者的基因检测中的二次数据使用:客户在何种程度上了解并关注?
Public Health Genomics. 2021;24(3-4):199-206. doi: 10.1159/000512660. Epub 2021 Feb 26.
3
Factors Associated with Acceptability, Consideration and Intention of Uptake of Direct-To-Consumer Genetic Testing: A Survey Study.与直接面向消费者的基因检测接受度、考虑因素及采用意愿相关的因素:一项调查研究
Public Health Genomics. 2018;21(1-2):45-52. doi: 10.1159/000492960. Epub 2018 Oct 25.
4
Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review.基于互联网的直接面向消费者的基因检测:一项系统综述
J Med Internet Res. 2015 Dec 14;17(12):e279. doi: 10.2196/jmir.4378.
5
Predictors of genetic testing decisions: a systematic review and critique of the literature.基因检测决策的预测因素:文献的系统评价与批判
J Genet Couns. 2014 Jun;23(3):263-88. doi: 10.1007/s10897-014-9712-9. Epub 2014 Apr 11.
6
Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies.直接面向消费者的基因检测与个人基因组学服务:近期实证研究综述
Curr Genet Med Rep. 2013 Sep;1(3):182-200. doi: 10.1007/s40142-013-0018-2.
7
Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature.从健康专业人员视角看直接面向消费者的基因检测:文献系统综述
J Community Genet. 2013 Apr;4(2):169-80. doi: 10.1007/s12687-012-0135-8. Epub 2013 Jan 16.
8
Increasing Public Awareness of Direct-to-Consumer Genetic Tests: Health Care Access, Internet Use, and Population Density Correlates.提高公众对直接面向消费者的基因检测的认识:与医疗保健可及性、互联网使用及人口密度的相关性
J Cancer Epidemiol. 2012;2012:309109. doi: 10.1155/2012/309109. Epub 2012 Jul 30.

本文引用的文献

1
The general public's understanding and perception of direct-to-consumer genetic test results.公众对直接面向消费者的基因检测结果的理解与认知。
Public Health Genomics. 2012;15(1):11-21. doi: 10.1159/000327159. Epub 2011 Jun 30.
2
Predictors of interest in direct-to-consumer genetic testing.直接面向消费者的基因检测的兴趣预测因素。
Psychol Health. 2011 Oct;26(10):1259-72. doi: 10.1080/08870446.2010.514607. Epub 2011 May 24.
3
Cancer-related direct-to-consumer advertising: a critical review.癌症相关的直接面向消费者的广告:批判性回顾。
Nat Rev Cancer. 2011 Feb;11(2):142-50. doi: 10.1038/nrc2999.
4
Effect of direct-to-consumer genomewide profiling to assess disease risk.直接面向消费者的全基因组分析评估疾病风险的效果。
N Engl J Med. 2011 Feb 10;364(6):524-34. doi: 10.1056/NEJMoa1011893. Epub 2011 Jan 12.
5
Science and regulation. Regulating direct-to-consumer personal genome testing.科学与监管。规范面向消费者的个人基因组检测。
Science. 2010 Oct 8;330(6001):181-2. doi: 10.1126/science.1194006.
6
Comparative effectiveness and personalized medicine: evolving together or apart?比较疗效学和个性化医学:是共同发展还是分道扬镳?
Health Aff (Millwood). 2010 Oct;29(10):1783-7. doi: 10.1377/hlthaff.2010.0642.
7
Inconsistent results, inaccurate claims plague direct-to-consumer gene tests.结果不一致、声称不准确困扰着直接面向消费者的基因检测。
JAMA. 2010 Sep 22;304(12):1313-5. doi: 10.1001/jama.2010.1328.
8
Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.ESHG 关于直接面向消费者的健康相关目的的基因检测的声明。
Eur J Hum Genet. 2010 Dec;18(12):1271-3. doi: 10.1038/ejhg.2010.129. Epub 2010 Aug 25.
9
Consumers' views of direct-to-consumer genetic information.消费者对直接面向消费者的基因信息的看法。
Annu Rev Genomics Hum Genet. 2010;11:427-46. doi: 10.1146/annurev-genom-082509-141604.
10
Genomic medicine--an updated primer.基因组医学——最新入门指南。
N Engl J Med. 2010 May 27;362(21):2001-11. doi: 10.1056/NEJMra0907175.